Ruby Therapeutics

08/27/2025

https://www.facebook.com/share/r/1aHyJA3Lcp/?mibextid=wwXIfr

08/19/2025

https://www.theguardian.com/society/2025/aug/13/adhd-medication-linked-to-lower-risk-of-suicidal-behaviours-study-suggests

Research also suggests the medication lowers risks of substance misuse, transport accidents and criminality

05/22/2025

04/17/2025

A recent New York Times Magazine article endangers patients’ health by baselessly questioning established science, willfully contorting experts’ words, and ignoring the grave consequences of untreated ADHD.

02/08/2025

A proposed rule from the Drug Enforcement Agency (DEA) that includes limiting Providers to no more than 50% of Schedule II prescriptions (stimulants for ADHD) via telemedicine. Meaning face to face appointments will be required for more than half of stimulant prescriptions. If passed, this rule would directly impact those with ADHD so it's important that you are informed of this proposed change. Please let the DEA know how you feel and post a comment!

Link: https://www.federalregister.gov/documents/2025/01/17/2025-01099/special-registrations-for-telemedicine-and-limited-state-telemedicine-registrations?fbclid=IwY2xjawITe39leHRuA2FlbQIxMQABHb1YBptjL8JErhSJW1F4Ybv-SFCc-3jHhr_fQiThCoAb_52dn86tFFR26g_aem_JpyAsVTGBqV8M3WWfq1CBw

The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (the "Ryan Haight Act") generally requires an in-person medical evaluation prior to the issuance of a prescription of controlled substances but provides an exception to this in-person medical evaluation requirement where the...